People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Rebelo joined Grey Health New York in December 2023 as executive creative director after spending nearly three-and-a-half years as chief creative officer at McCann Health New Jersey.

Tony Ezell serves as the executive vice president, president of the Americas for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New ...

A new study funded by Eli Lilly reports that people without diabetes ... chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, about this research.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...

Eli Lilly (LLY 1.80%) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...

An Eli Lilly exec said the company’s experimental ... prescription drugs are seen next to a pill bottle on July 23, 2024 in New York City. - Image: Spencer Platt / Staff (Getty Images) Viking ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Eli Lilly and Company (NYSE: LLY) today announced at a press conference in Washington, D.C., plans to bolster its domestic medicine production across therapeutic areas by building four new ...